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http://dx.doi.org/10.1016/j.jmii.2012Streptomyces griseus causes subcutaneous mycetomas in felines and dolphins; however, hu-
man mycetoma caused by S. griseus has not previously been reported. Hereby, we report a
case of a 50-year-old female presenting with swelling in the left upper cervical region and
the left cheek that lasted for 6 months. The fine needle aspiration (FNA) performed on the
swelling yielded purulent material; on microscopy, actinomycosis was diagnosed. On culturing,
the pus grew S. griseus. To the best of our knowledge, this is the first reported case of human
mycetoma caused by S. griseus.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Mycetoma is a localized chronic suppurative infection of
subcutaneous tissue, commonly affecting the foot.1 It is
either actinomycotic or eumycotic in etiology. Actinomy-
cotic mycetoma is most commonly caused by the genus
Actinomadura, followed by Nocardia and Streptomyces
species.2 Among the genus Streptomyces, more than 3100
Streptomyces species have been described.1 Of these,
S. somaliensis has been the commonest etiologic agent
causing human infections.3 It has also been identified asof Microbiology, Government
160030, India.
il.com (N. Singla).
an Society of Microbiology. Publ
.12.002one of the principal etiologic agents of actinomycetoma in
South America, Africa, India, Mexico, Malaysia, and the
USA.1 As far as S. griseus is concerned, there is scanty
literature available on human infection by this organism4,5
and no case of human mycetoma by Streptomyces griseus
has been reported to date, to the best of our knowledge.
We report a rare case of cervicofacial mycetoma caused by
S. griseus.
Case report
A 50-year-old female presented with swelling in the left
upper cervical region and left cheek for 6 months. History
of suppuration in the swelling with pus exuding from mul-
tiple sites was present. There was history of dysphagia, but
no history of dyspnea, dysphonia, or fever was present.ished by Elsevier Taiwan LLC. All rights reserved.
Figure 2. Smear showing aggregates of radiating filaments of
Streptomyces griseus amidst acute inflammatory cells (Gram’s
stain, 400).
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8  6 cm in the left upper cervical region extending to the
left cheek (Fig. 1). The swelling was tender, hard in con-
sistency, and fixed to the underlying tissues. It had tiny
ulcerated areas with yellowish discoloration. Intra-oral
examination revealed swelling in the floor of the mouth,
which was red and indurated. Her hemogram and chest
roentgenogram were found to be within normal limits. No
other abnormality was detected on systemic examination.
The fine needle aspiration (FNA) done from the left cervical
swelling yielded purulent material, which was subjected to
cytological and microbiological examination.
Cytologic findings
Smears were stained with May-Grunwald Giemsa (MGG),
Hematoxylin and Eosin (H&E), Gomori’s Methenamine Silver
(GMS), Periodic-acid Schiff (PAS), Gram’s, and Ziehl Neelsen
(ZN) stainings. FNA smears showed mixed inflammatory
infiltrate consisting of predominantly neutrophils, a few
lymphocytes, macrophages, occasional plasma cells and
eosinophils. In addition, numerous aggregates and colonies
were seen interspersed within the infiltrate. The colonies
were composed of slender and delicate filaments, which
were appreciated under higher magnification. These fila-
mentous organisms were PAS positive, Gram positive
(Fig. 2), and were highlighted by GMS stains. The filaments
were negative with ZN stain. A cytologic diagnosis of acti-
nomycosis was made.
Microbiological findings
The pus aspirated was also sent for culture and sensitivity
testing. The specimen was inoculated on blood agar and
MacConkey’s agar. The growth was visible as chalky white,
membranous to granular colonies within 48 hours of incu-
bation at 37C. It was considered to be belonging to the
genus Streptomyces and was sent to the Public Health
Laboratory Services, Bristol, United Kingdom for confirma-
tion, where it was finally identified to be S. griseus. Sub-
sequent to the diagnosis, the patient was put onFigure 1. Clinical presentation of the patient showing pus
exuding from multiple sites.intravenous crystalline penicillin. She responded well to
treatment, and the lesion subsided within a period of 8
weeks.
Discussion
S. griseus is an aerobic actinomycete that commonly oc-
curs in soil as a saprophyte. S. griseus was first isolated by
Krainsky in 1914 from Russian soil during a World War I
outbreak. In 1915, Waksman isolated a strain from New
Jersey soil and called it Actinomyces griseus. In 1943,
Actinomyces griseus was changed to Streptomycin griseus,
and subsequently the common nomenclature Streptomyces
griseus (Krainsky 1914) Waksman and Henrici 1948 followed
for the organism.6 Traditionally, the organism has been
known for production of antibiotics used to treat bacterial,
mycobacterial, fungal, and parasitic infections.7 A review
of the literature reveals only a few case reports of human
infection by S. griseus. Gugnani et al5 reported five cases
of pulmonary infection due to S. griseus on sputum culture.
S. griseus was also isolated from a case of brain abscess.4
S. griseus is known to cause subcutaneous mycetomas in
felines and captive bottlenose dolphins, and Gugnani et al
tried to produce experimental mycetoma in laboratory
mice.8 However, isolation of S. griseus as an etiologic
agent in human mycetoma has not been documented to
date.
Diagnosis of mycetoma is established on combination of
clinical features, cytologic or histopathologic examination,
serologic studies, and culture. The Actinomycetales include
Actinomycetes, Nocardia, and Streptomyces. Streptomyces
are differentiated from Actinomycetes by being aerobic
and from Nocardia by being non-acid fast organisms that
do not fragment into bacillary forms. Furthermore, species
of the genus Streptomyces are characterized by formation
of extensive branched aerial filaments with long chains
of conidia and the cell wall made of peptidoglycan
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culturing, help to differentiate Streptomyces from other
actinomycetes, particularly Nocardia species. However, the
identification and speciation of Streptomyces is a complex
task because these organisms show marked variability and
genetic instability. To date, culture remains the gold
standard for final etiological diagnosis. On culturing,
Streptomyces produces dry, chalky, gray-white colonies
that emit pungent, musty odor.9
S. griseus was previously considered to be of doubtful
pathogenicity.3 The reference laboratory of the Centers
for Disease Control and Prevention (CDC) has reported
incidence of S. griseus to be 7.7% of clinical isolates,
following Nocardia and Actinomadura species.10 This data
suggests that Streptomyces infection is under-reported and
invasive Streptomyces infection may be more common.
A high index of suspicion is necessary to identify these
infections from clinical specimens. It is also stressed that
samples should be investigated both cytologically and
microbiologically. In the case described here, on cytolog-
ical examination, an erroneous diagnosis of actinomycosis
was made, but it was the growth from culture that helped
in reaching the final diagnosis of S. griseus. It is also
important to note that as such scant data is available on
effective treatment of Streptomyces infection. Mycetoma
caused by Streptomyces is often treated with penicillin,
sulphonamides, or tetracycline but the cure rate may be
low with sulphonamides (the drug of choice for Nocardia).
Isolates of S. griseus referred to the CDC have been found
to be resistant to ampicillin (80%), sulfamethoxazole (43%),
cotrimoxazole (29%), and ciprofloxacin (57%).10 Resistance
patterns in the case of S. griseus must be interpreted
cautiously because it can synthesize antibiotics, poten-
tially confounding the results of in vitro susceptibility
testing. To the best of our knowledge, this is the first case
report of mycetoma in humans as a result of S. griseus
infection.Acknowledgments
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